References
Nov 16, 1995·The New England Journal of Medicine·J ShepherdC J Packard
Oct 3, 1996·The New England Journal of Medicine·F M SacksE Braunwald
Jan 16, 1997·The New England Journal of Medicine·UNKNOWN Post Coronary Artery Bypass Graft Trial Investigators
May 2, 1997·Cell·M S Brown, J L Goldstein
Jun 5, 1998·JAMA : the Journal of the American Medical Association·J R DownsA M Gotto
Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Sep 24, 1999·The Journal of Clinical Investigation·C WeyerR E Pratley
Feb 7, 2001·Circulation·D J FreemanA Gaw
Nov 7, 2001·FEBS Letters·L H Chamberlain
Jun 22, 2002·JAMA : the Journal of the American Medical Association·Patrick W J C SerruysUNKNOWN Lescol Intervention Prevention Study (LIPS) Investigators
Jul 13, 2002·Lancet·UNKNOWN Heart Protection Study Collaborative Group
Aug 31, 2002·Current Medical Research and Opinion·Vasilios G AthyrosAthanasios G Kontopoulos
Nov 30, 2002·Lancet·James ShepherdUNKNOWN PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Apr 11, 2003·Lancet·Peter S SeverUNKNOWN ASCOT investigators
Mar 10, 2004·The New England Journal of Medicine·Christopher P CannonUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
Aug 25, 2004·Lancet·Helen M ColhounUNKNOWN CARDS investigators
Sep 1, 2004·JAMA : the Journal of the American Medical Association·James A de LemosUNKNOWN Investigators
Nov 9, 2004·Atherosclerosis. Supplements·Hiroshi MabuchiRyoyu Takeda
Mar 10, 2005·The New England Journal of Medicine·John C LaRosaUNKNOWN Treating to New Targets (TNT) Investigators
Nov 17, 2005·JAMA : the Journal of the American Medical Association·Terje R PedersenUNKNOWN Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group
May 11, 2006·Diabetologia·M NakataT Yada
Jun 28, 2006·Diabetes Care·Robert H KnoppStuart J Pocock
Aug 11, 2006·The New England Journal of Medicine·Pierre AmarencoUNKNOWN Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators
Sep 7, 2006·European Heart Journal·Shaheeda AhmedEugene Braunwald
Oct 3, 2006·Lancet·Haruo NakamuraUNKNOWN MEGA Study Group
Jan 15, 2008·Lancet·P M KearneyC Baigent
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Mar 21, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Joseph L Goldstein, Michael S Brown
Sep 30, 2009·Current Medical Research and Opinion·Leiv OseValerie Arneson
Oct 2, 2009·Diabetes Care·Swapnil N RajpathakPaul M Ridker
Nov 17, 2009·Diabetes Research and Clinical Practice·William L BakerCraig I Coleman
Feb 20, 2010·Lancet·Naveed SattarIan Ford
Mar 17, 2010·Diabetologia·J K KruitM R Hayden
May 14, 2010·Current Opinion in Lipidology·Janine K KruitMichael R Hayden
Nov 12, 2010·Lancet·UNKNOWN Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative GroupRory Collins
Apr 2, 2011·Journal of the American College of Cardiology·David D WatersPhilip Barter
Jun 23, 2011·JAMA : the Journal of the American Medical Association·David PreissKausik K Ray
Aug 5, 2011·Diabetes, Obesity & Metabolism·J GumprechtN Hounslow
Dec 30, 2011·International Journal of Cardiology·Kwang Kon KohEak Kyun Shin
Jan 11, 2012·Archives of Internal Medicine·Annie L CulverYunsheng Ma
May 23, 2012·Lancet·UNKNOWN Cholesterol Treatment Trialists' (CTT) CollaboratorsC Baigent
Jun 9, 2012·European Journal of Preventive Cardiology·Steen StenderNeil Hounslow
Aug 14, 2012·Lancet·Paul M RidkerRobert J Glynn
Dec 12, 2012·Journal of the American College of Cardiology·David D WatersTerje R Pedersen
Feb 27, 2013·The Cochrane Database of Systematic Reviews·Fiona TaylorShah Ebrahim
Nov 1, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Eliano Pio NavareseHarry Suryapranata
Nov 14, 2013·Journal of the American Pharmacists Association : JAPhA
Nov 19, 2013·Journal of the American College of Cardiology·Neil J StoneUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines